Alfresa HoldingsALFRY 75 Days Inventory is 24.64 as of Mar. 2026, which is 15% above its 10-year median of 21.40. GuruFocus rates ALFRY with a GF Score™ of 75/100 and a GF Value™ of $16.31 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 115 Medical Distribution companies, Alfresa Holdings ranks better than 86.96% on this metric.
The historical rank and industry rank for Alfresa Holdings's Days Inventory or its related term are showing as below:
ALFRY'
s Days Inventory Range Over the Past 10 Years
Min: 20.01 Med: 21.4 Max: 22.44
Current: 22.31
During the past 13 years, Alfresa Holdings's highest Days Inventory was 22.44. The lowest was 20.01. And the median was 21.40.
ALFRY's Days Inventory is ranked better than 86.96% of 115
companies
in the Medical Distribution industry
Industry Median: 57.26
vs ALFRY: 22.31
Alfresa Holdings's Days Inventory
declined
from Mar. 2025 (25.48) to Mar. 2026 (24.64).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Alfresa Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 was 3.70.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Alfresa Holdings's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.25.
Alfresa Holdings (OTCPK:ALFRY) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Alfresa Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Alfresa Holdings's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Alfresa Holdings Days Inventory Related Terms
Alfresa Holdings Days Inventory Historical Data
* Premium members only.
The historical data trend for Alfresa Holdings's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Alfresa Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alfresa Holdings Days Inventory vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Alfresa Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Alfresa Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alfresa Holdings (ALFRY) has a Days Inventory of 24.64 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Alfresa Holdings and its competitors. This is 15% above median its historical median of 21.40. Over the past decade, Alfresa Holdings' Days Inventory has ranged from 20.01 to 22.44. According to the industry distribution chart, Alfresa Holdings ranks #15 out of 115 companies in the Medical Distribution industry, placing it in the top 13%.
Is Alfresa Holdings' Days Inventory too high?
Alfresa Holdings' current Days Inventory of 24.64 is 15% above median its 10-year median of 21.40. Over the past 10 years, this metric has ranged from a low of 20.01 to a high of 22.44. The Medical Distribution industry median Days Inventory is 57.26. Alfresa Holdings' value of 24.64 is 57% below this industry median. Based on the distribution chart, Alfresa Holdings ranks #15 out of 115 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Alfresa Holdings has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alfresa Holdings' Days Inventory compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Alfresa Holdings ranks #15 out of 115 companies for Days Inventory. This places Alfresa Holdings in the top 13% of its industry — outperforming the majority of peers. The industry median Days Inventory is 57.26. Alfresa Holdings' value of 24.64 is 57% below this benchmark. Historically, Alfresa Holdings' own Days Inventory has ranged from 20.01 to 22.44 over the past decade. While the company's 10-year median is 21.40 vs. the industry median of 57.26, Alfresa Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Distribution company?
The median Days Inventory among Medical Distribution companies is 57.26, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alfresa Holdings's current Days Inventory of 24.64 is 57% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Alfresa Holdings and its competitors. For the Medical Distribution industry, the median Days Inventory is 57.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alfresa Holdings's current Days Inventory is 24.64, which is 15% above median its own 10-year median of 21.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alfresa Holdings stock overvalued right now?
Based on GuruFocus' analysis, Alfresa Holdings (ALFRY) is currently considered Modestly Undervalued. The stock's GF Value™ is $16.31, compared to a current price of $13.80 — trading 15.4% below its estimated fair value. The current Days Inventory is 24.64, which is 15% above median its 10-year median of 21.40 and 57% below the Medical Distribution industry median of 57.26. Alfresa Holdings' overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Alfresa Holdings (ALFRY), the current Days Inventory is 24.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alfresa Holdings (ALFRY) Overvalued in 2026?
Based on GuruFocus' analysis, Alfresa Holdings stock appears to be undervalued.
The current stock price of $13.80 is trading 15.4% below its estimated GF Value™ of $16.31.
GuruFocus considers Alfresa Holdings to be Modestly Undervalued.
Key valuation signals for ALFRY:
Days Inventory: 24.64 (15% above median its 10-year median of 21.40)
GF Value™: $16.31 vs. price of $13.80 (15.4% below fair value)
Industry Position: 57% below the Medical Distribution median (#15 of 115)
No single metric tells the full story. See the ALFRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alfresa Holdings Corp is engaged in the pharmaceutical distribution and related businesses. The company operates through four reportable segments: Wholesale business of medical drugs, Self-Medication Wholesale Business, Pharmaceutical Manufacturing Business, and Medical-Related Business. Its operations include the wholesale of ethical and over-the-counter pharmaceuticals, the manufacture and sale of pharmaceuticals, medical testing reagents, and medical equipment, as well as the operation of dispensing pharmacies.
75GF Score
Get the complete analysis for ALFRY
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALFRY has been successfully added to your 
